Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CFSAN program priorities

This article was originally published in The Tan Sheet

Executive Summary

Center solicits comments toward development of its 2001 program priorities in a June 23 Federal Register notice. The format will be similar to the 2000 workplan, which divides CFSAN's activities into "A" and "B" list items under five program areas: premarket review of food ingredients; nutrition, health claims and labeling; dietary supplements; chemical and other contaminants; and cosmetics. About half of CFSAN's budget is devoted to the Food Safety Initiative, with the rest divided among other areas. Among CFSAN's 2000 "A"-list goals are ephedra regulation, supplement enforcement streamlining, supplement GMPs and AE monitoring, and Pearson v. Shalala implementation (1"The Tan Sheet" Feb. 14, p. 12)

You may also be interested in...

Dietary Supplement Enforcement Procedure Streamlining Planned By CFSAN

Consolidating FDA's enforcement process with regard to inappropriate dietary supplement claims is one of the Center for Food Safety & Applied Nutrition's "A-list" goals for 2000.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts